2022 New Drug Approvals | RheumNow
2021-2022 New FDA Drug Approvals and New Indications
2021-2022 New FDA Drug Approvals and New Indications
A clinical trial has shown that self-administered acupressure (SAA) is effective in relieving knee osteoarthritis (KOA) patients.
Enthesitis can be a challenge for clinicians to identify, evaluate, and manage in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). It affects 27-35%…
BackgroundImmunotherapy targeting factors related to immune imbalance has been widely employed for RA treatment. This study aimed to evaluate the efficacy an…
Dr. Jack Cush reviews regulatory reports, news and novel journal articles – this week focusing on Sjogren’s, ILD, Gout and Uveitis.
A population-based cohort has demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) use in gout patients is superior to sulfonylurea therapy in lowering the risk of incident…
Since its initial description in the late 19th century, sarcoidosis has been extensively studied. Although the general mechanism of immune activation is known, …
This extended follow-up of a randomized clinical trial compares the long-term incidence of total knee arthroplasty on the study knee between patients undergoing arthroscopic surgery…
Patients diagnosed with pIMID have a fourfold higher risk of mortality when followed into early adulthood compared with reference individuals. This underlines the severe disease…
AbstractObjective. To describe the clinical features of Chinese patients with HCQ-induced pigmentation and analyse the potential risk factors associated wi
ABSTRACT Background: Chikungunya fever is an emerging global infection transmitted by Aedes…